| Dr Kevin Mills Mcneill, MD | |
|
129 Calumet Dr, Madison, MS 39110-9298 | |
| (601) 605-8956 | |
| Not Available |
| Full Name | Dr Kevin Mills Mcneill |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 129 Calumet Dr, Madison, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013288919 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Mills Mcneill, MD 129 Calumet Dr, Madison, MS 39110-9298 Ph: (601) 605-8956 | Dr Kevin Mills Mcneill, MD 129 Calumet Dr, Madison, MS 39110-9298 Ph: (601) 605-8956 |
News Archive
According to new recommendations in the December 10 issue of The American Journal of Cardiology (AJC), published by Elsevier, new research is called for and patients with severe forms of the skin disease psoriasis should receive evaluation and possible treatment to reduce their risk of coronary artery disease (CAD).
Endoscopic sinus surgery is performed for patients who have chronic or acute sinusitis that persists for more than six weeks after maximum medical therapy has been tried.
The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19.
With more and more states and regions legalizing the use of medical marijuana or cannabis, experts are also looking at the long term effects of marijuana use and its safety. According to a new study published this week in the journal The Lancet Psychiatry, frequent use of marijuana can lead to psychotic episodes.
Whitehead Institute Founding Member Rudolf Jaenisch has been named a recipient of the 2011 Warren Triennial Prize of Massachusetts General Hospital.
› Verified 5 days ago